Shah, D., Sparano, F., Luo, C., Krepper, D., Giesinger, J. M., Baldi, T., Duncan, E., Pe, M., Chakraborty, R., & Efficace, F. (2024). Patient-reported outcome domains in multiple myeloma randomized controlled trials and association with survival outcomes. Annals of Hematology, 103(12), 5849–5859. https://doi.org/10.1007/s00277-024-06129-5

Wang, W., Zhang, W., Su, L., Liu, L., Gao, Y., Wang, Q., Su, H., Song, Y., Zhang, H., Shen, J., Jing, H., Wang, S., Cen, X., Liu, H., Liu, A., Li, Z., Luo, J., He, J., Wang, J., … Zhou, D. (2024). Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in China. Annals of Hematology, 103(8), 3061–3069. https://doi.org/10.1007/s00277-024-05708-w

Charalampous, C., Shah, D., Kumar, S., & Chakraborty, R. (2024). Thromboprophylaxis in multiple myeloma: a case-based review with practical guidelines. Annals of Hematology. https://doi.org/10.1007/s00277-024-05733-9